News
TD Cowen Maintains Buy on Gilead Sciences, Lowers Price Target to $85
26 Apr 24
News, Price Target, Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Lowers Price Target to $78
26 Apr 24
News, Price Target, Analyst Ratings
Needham Reiterates Hold on Gilead Sciences
26 Apr 24
News, Reiteration, Analyst Ratings
Gilead Sciences Q1 2024 Adj EPS $(1.32) Beats $(1.49) Estimate, Sales $6.10B Miss $6.34B Estimate
25 Apr 24
Earnings, Earnings Beats, Earnings Misses, News
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
25 Apr 24
Cryptocurrency, Equities, Large Cap, Macro Notification, Market Summary, Mid Cap, Sector ETFs, Bonds, Broad U.S. Equity ETFs, Commodities, Treasuries, Econ #s, Top Stories, Movers, Tech, ETFs
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
25 Apr 24
News, Dividends, Price Target, Pre-Market Outlook, Markets, Trading Ideas
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
25 Apr 24
Earnings, Equities, News, Futures, Previews, Top Stories, Economics, Federal Reserve, Pre-Market Outlook, Markets, Movers, Trading Ideas
HSBC Upgrades Gilead Sciences to Hold, Announces $69 Price Target
24 Apr 24
News, Upgrades, Price Target, Analyst Ratings
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
24 Apr 24
Biotech, News, Health Care, Top Stories, Movers, General
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
21 Apr 24
Analyst Color, Equities, News, Top Stories, Tech, Trading Ideas
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
19 Apr 24
Analyst Ratings
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
19 Apr 24
Biotech, Large Cap, News, Penny Stocks, Health Care, FDA, General
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
17 Apr 24
News, Trading Ideas
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
11 Apr 24
Long Ideas, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
10 Health Care Stocks With Whale Alerts In Today's Session
9 Apr 24
Options
Starbucks, Gilead And Ambev Are At 52-Week Lows: Should You Buy The Dip?
8 Apr 24
Long Ideas, Top Stories, Trading Ideas
10 Health Care Stocks Whale Activity In Today's Session
3 Apr 24
Options
CORRECTION: Wells Fargo On Mar. 4 Lowered Gilead PT From $84 To $78
3 Apr 24
Price Target, Analyst Ratings
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,000 Today
3 Apr 24
News, Trading Ideas
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
1 Apr 24
Analyst Color, Biotech, News, Downgrades, Health Care, Top Stories, General
Press releases
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
26 Apr 24
Press Releases
Gilead Sciences Announces First Quarter 2024 Financial Results
25 Apr 24
Press Releases
Biotech Innovations Paving the Way in Breast Cancer Fight
11 Apr 24
Small Cap, Opinion, Press Releases
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
8 Apr 24
Press Releases
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
28 Mar 24
Press Releases
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
28 Mar 24
Press Releases
Gilead Sciences Announces Completion of Acquisition of CymaBay
22 Mar 24
Press Releases
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
18 Mar 24
Press Releases
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
11 Mar 24
Press Releases
Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
6 Mar 24
Press Releases
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
6 Mar 24
Press Releases
New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19
5 Mar 24
Press Releases
Gilead's Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
5 Mar 24
Press Releases
Gilead Announces Funding Initiative to Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.
27 Feb 24
Press Releases
Gilead to Present Late-Breaking Data and Real-World Evidence Highlighting Innovative Antiviral Portfolio and Research Pipeline at CROI 2024
26 Feb 24
Press Releases
CYMABAY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CymaBay Therapeutics, Inc. - CBAY
16 Feb 24
Press Releases
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
12 Feb 24
Press Releases
Gilead Named One of America's Most JUST Companies by JUST Capital and CNBC
9 Feb 24
Press Releases
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2024 Dividend
6 Feb 24
Press Releases
Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results
6 Feb 24
Press Releases